6,311 The Clorox Company $CLX Shares Bought by Sterling Capital Management LLC

Sterling Capital Management LLC lifted its position in shares of The Clorox Company (NYSE:CLX) by 174.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,935 shares of the company’s stock after purchasing an additional 6,311 shares during the period. Sterling Capital Management LLC’s holdings in Clorox were worth $805,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. BlackRock Inc. acquired a new stake in Clorox in the 2nd quarter valued at about $958,640,000. Bank of America Corp DE bought a new position in Clorox during the second quarter worth about $179,780,000. Royal Bank of Canada increased its position in Clorox by 20.1% during the first quarter. Royal Bank of Canada now owns 1,418,204 shares of the company’s stock worth $146,969,000 after buying an additional 237,301 shares during the last quarter. Bank of New York Mellon Corp acquired a new position in Clorox during the second quarter worth approximately $123,154,000. Finally, Confluence Investment Management LLC increased its position in Clorox by 33.8% during the second quarter. Confluence Investment Management LLC now owns 1,247,644 shares of the company’s stock worth $119,075,000 after buying an additional 315,069 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Clorox

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Clorox’s annualized $5 dividend offers a yield of approximately 5.7%, which may attract income-focused investors. The November 2 earnings report could provide a catalyst if cash flow shows the payout remains well covered. Is Clorox’s 6% Dividend Yield Safe?
• Neutral Sentiment: Investors are focused on the upcoming fiscal first-quarter results for evidence that Clorox can deliver its fiscal 2027 earnings outlook of $5.70 to $6.00 per share and stabilize organic sales. Clorox Dividend and Earnings Preview
• Negative Sentiment: Zacks Research reduced its fiscal 2027 third-quarter EPS estimate to $1.56 from $1.62 and its fourth-quarter estimate to $1.77 from $1.82. The cuts reinforce concerns about slowing earnings momentum; Zacks maintains a “Hold” rating. Clorox Earnings Estimate Changes
• Negative Sentiment: UBS expects fiscal first-quarter organic sales growth to remain pressured, while cost inflation weighs on earnings. This could make it harder for Clorox to meet expectations and protect margins. Clorox Fiscal Q1 Organic Sales Outlook
• Negative Sentiment: Recent coverage highlights declining sales and an even sharper drop in profits, along with higher costs tied to integrating a recent acquisition. Debt has reportedly doubled to roughly $5 billion, increasing balance-sheet and dividend-coverage risk. Macroeconomic Headwinds are Hitting Clorox From All Sides

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. TD Cowen cut their price objective on Clorox from $85.00 to $80.00 and set a “hold” rating for the company in a research report on Tuesday, October 13th. BNP Paribas Exane decreased their target price on Clorox from $97.00 to $95.00 and set a “neutral” rating on the stock in a report on Monday, July 20th. Evercore set a $99.00 price target on Clorox in a research note on Tuesday, August 4th. Wall Street Zen downgraded Clorox from a “hold” rating to a “sell” rating in a report on Saturday, October 3rd. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Clorox from $95.00 to $83.00 and set an “underweight” rating for the company in a research report on Monday, October 19th. Twelve equities research analysts have rated the stock with a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Reduce” and a consensus target price of $93.57.

Clorox Trading Up 0.7%

Shares of CLX opened at $87.36 on Wednesday. The Clorox Company has a 52 week low of $79.12 and a 52 week high of $128.90. The firm’s 50-day simple moving average is $89.74 and its 200 day simple moving average is $100.28.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, August 3rd. The company reported $1.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.02. The company had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.91 billion. During the same quarter last year, the business earned $2.87 earnings per share. The company’s revenue was down 2.0% on a year-over-year basis. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. On average, equities analysts forecast that The Clorox Company will post 5.66 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Wednesday, October 28th will be paid a dividend of $1.25 per share. The ex-dividend date is Wednesday, October 28th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 5.7%.

Clorox Company Profile

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt’s Bees personal care items.